Stroke Recovery System

About Cortigent

Cortigent is a neuroscience-focused medical device company, spun out from Vivani Medical, with a mission to restore lost body functions via targeted brain-surface stimulation. Its core achievement is building upon the legacy of the first FDA-approved retinal prosthesis (Argus II) to develop the next-generation Orion visual cortical prosthesis and a stroke motor recovery system. The company's strategy leverages a proprietary high-channel-count platform to address large neurological indications, though its path is complicated by its subsidiary status and a recently withdrawn planned spin-off from its parent company.

Therapeutic Areas